These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 206576)

  • 21. Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment.
    Burger PC
    Semin Oncol; 1986 Mar; 13(1):16-26. PubMed ID: 3006257
    [No Abstract]   [Full Text] [Related]  

  • 22. Cell kinetic analyses of human malignant brain tumors (gliomas).
    Hoshino T; Wilson CB
    Cancer; 1979 Sep; 44(3):956-62. PubMed ID: 225007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automated image analysis, histologic malignancy grading, and survival in patients with astrocytic gliomas. Prognostic significance of nuclear count and nuclear area fraction.
    Klinken LH; Diemer NH; Gjerris F
    Clin Neuropathol; 1984; 3(3):107-12. PubMed ID: 6565536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas.
    Müller W; Afra D; Schröder R
    Acta Neurochir (Wien); 1977; 37(1-2):75-91. PubMed ID: 195444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Quantitative histological observations in gliomas (author's transl)].
    Martin H; Schmidt D; Heim I; Scholze K; Tanner G
    Zentralbl Allg Pathol; 1980; 124(1-2):31-9. PubMed ID: 6251667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathology, classification, and grading of gliomas.
    Kleihues P; Soylemezoglu F; Schäuble B; Scheithauer BW; Burger PC
    Glia; 1995 Nov; 15(3):211-21. PubMed ID: 8586458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
    Schiff D; Desjardins A; Cloughesy T; Mikkelsen T; Glantz M; Chamberlain MC; Reardon DA; Wen PY
    Cancer; 2016 Feb; 122(4):582-7. PubMed ID: 26588662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Survival analysis for high-grade glioma patients who received comprehensive treatment].
    Liu G; Jiang R; Xu C; Zhou J; Liu F; He Z; Liu Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):388-393. PubMed ID: 29774874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell adoptive immunotherapy of newly diagnosed gliomas.
    Plautz GE; Miller DW; Barnett GH; Stevens GH; Maffett S; Kim J; Cohen PA; Shu S
    Clin Cancer Res; 2000 Jun; 6(6):2209-18. PubMed ID: 10873070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
    Born PW; Broholm H; Laursen H
    Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automated image analysis of gliomas an objective and reproducible method for tumor grading.
    Martin H; Voss K; Hufnagl P; Frölich K
    Acta Neuropathol; 1984; 63(2):160-9. PubMed ID: 6730918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age.
    Ferris SP; Goode B; Joseph NM; Kline CN; Samuel D; Gupta N; Bollen A; Perry A; Mueller S; Solomon DA
    Acta Neuropathol; 2016 Jul; 132(1):153-5. PubMed ID: 27161253
    [No Abstract]   [Full Text] [Related]  

  • 33. [Gemistocytic astrocytomas].
    Matsko DE; Zrelov AA; Ulitin AY; Matsko MV; Skliar SS; Baksheeva AO; Imyanitov EN
    Arkh Patol; 2018; 80(4):27-38. PubMed ID: 30059069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Computer assisted grading of gliomas of the astrocytoma/glioblastoma groups].
    Kolles H; von Wangenheim A; Niedermayer I; Vince GH; Feiden W
    Verh Dtsch Ges Pathol; 1994; 78():427-31. PubMed ID: 7534014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
    Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
    PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Automated morphometric and densitometric investigations and mathematical classification of gliomas (author's transl)].
    Martin H; Schmidt D; Voss K
    Zentralbl Allg Pathol; 1981; 125(5):414-28. PubMed ID: 7331563
    [No Abstract]   [Full Text] [Related]  

  • 37. Grading astrocytomas.
    Adelman LS
    Neurosurg Clin N Am; 1994 Jan; 5(1):35-41. PubMed ID: 8124092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The clinical picture and surgical prospects of rapidly growing gliomas].
    Walter W; Schettler G; Müller W
    Dtsch Z Nervenheilkd; 1969; 196(1):1-19. PubMed ID: 4307961
    [No Abstract]   [Full Text] [Related]  

  • 39. Brainstem neoplasms.
    Molloy P; Sutton L; Yachnis AT; Rebsamen S
    Med Pediatr Oncol; 1995 Jun; 24(6):379-87. PubMed ID: 7715544
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas.
    Safdari H; Hochberg FH; Richardson EP
    Surg Neurol; 1985 Mar; 23(3):221-6. PubMed ID: 2983448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.